[1]
2012. Evaluation of the anti-inflammatory activity and ulcerogenic liability of 5-(3-chloro-1-benzothien -2-yl)-4-phenyl-4H-1,2,4-triazole-3-thiol. Asian Journal of Pharmaceutical and Health Sciences. 2, 4 (Dec. 2012), 535–538. DOI:https://doi.org/10.5530/nyp80b28.